CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Quanterix Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Quanterix Corp
900 Middlesex Turnpike
Phone: (302) 658-7581p:302 658-7581 BILLERICA, MA  01821  United States Ticker: QTRXQTRX
Business Summary
Quanterix Corporation is a life sciences company. The Company is focused on ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development proprietary digital Simoa detection technology enables customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. Its Simoa bead-based digital immunoassays utilize the basic principles of conventional bead-based sandwich ELISA. The HD-X is the Company's flagship instrument that empowers biomarker research and accelerates drug development. Its SR-X instrument is a compact benchtop instrument with a lower price point, more flexible assay preparation, and a wider range of applications. The Company's Spatial Biology solutions measure protein expression and cellular phenotypes within intact tissue while preserving spatial context and tissue architecture.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board William P.Donnelly 63 1/19/2026 8/17/2023
President, Chief Executive Officer, Director Everett V.Cunningham 58 1/19/2026 1/19/2026
Chief Financial Officer, Treasurer VandanaSriram 51 8/21/2023 8/21/2023
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Akoya Biosciences UK Ltd. 2 Minton Place Victoria Road Bicester United Kingdom
Akoya Biosciences Inc 100 Campus Drive, 6Th Floor MARLBOROUGH MA United States
Emission Inc. 2500 NE Inner Loop Georgetown TX United States

Business Names
Business Name
Akoya Biosciences Inc
Akoya Biosciences UK Ltd.
Akoya Biosciences US Ltd.
11 additional Business Names available in full report.

General Information
Number of Employees: 450 (As of 12/31/2025)
Outstanding Shares: 46,939,975 (As of 2/24/2026)
Shareholders: 68
Stock Exchange: NASD
Federal Tax Id: 208957988
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 31, 2026